Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Sale of product	$ 7,536,860	$ 6,849,150
Cost of product	4,559,745	4,313,543
Gross profit	2,977,115	2,535,607
Operating costs and expenses:
Salaries and contract labor	1,690,034	1,801,433
General, administrative and consulting	1,608,759	2,126,379
Research and development	464,206	706,048
Total operating expenses	3,762,999	4,633,860
Net operating loss	(785,884)	(2,098,253)
Other income (expense):
Other income	86,534	22,929
Equity in net income of affiliate	96,058	57,650
Interest income	586	1,147
Interest expense	(936,525)	(469,035)
Total other (expense)	(753,347)	(387,309)
Net loss	(1,539,231)	(2,485,562)
Income/(loss) attributable to noncontrolling interest	5,846	(23,717)
Net loss attributable to International Isotopes Inc.	$ (1,545,077)	$ (2,461,845)
Net loss per common share - basic and diluted	$ 0.00	$ (0.01)
Weighted average common shares outstanding - basic and diluted	369,334,615	365,201,905